Fulgent Genetics (FLGT) Cash from Operations (2015 - 2026)

Fulgent Genetics has disclosed Cash from Operations across 12 years of filings, most recently posting 7097000.0 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 7097000.0, up 260.17% year-over-year; the trailing twelve-month figure through Mar 2026 was 90110000.0 (down 1062.41% YoY), and the FY2025 annual result was 101638000.0, down 582.61% from the prior year.
• Cash from Operations came in at 7097000.0 for Q1 2026 at Fulgent Genetics, up from 78143000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 188411000.0 in Q1 2022 to a low of 78143000.0 in Q4 2025.
• The 5-year median for Cash from Operations is 9737000.0 (2023), against an average of 12178941.18.
• Across the five-year window, Cash from Operations slumped 804.11% in 2025 and jumped 260.17% in 2026, its largest moves.
• Fulgent Genetics' Cash from Operations stood at 33207000.0 in 2022, then plunged by 55.03% to 14933000.0 in 2023, then surged by 67.53% to 25018000.0 in 2024, then plunged by 412.35% to 78143000.0 in 2025, then surged by 109.08% to 7097000.0 in 2026.
• The last three Cash from Operations figures came in at 7097000.0 (Q1 2026), 78143000.0 (Q4 2025), and 11107000.0 (Q3 2025), per Business Quant data.